Approval · Notice of Compliance 12887 · 2011
LODALIS: Notice of Compliance 12887
Issued December 28, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12887
- Date
- December 28, 2011
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Therapeutic class
- Bile Acid Sequestrant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LODALIS | 02373955 | Marketed |
Medicinal ingredients
- COLESEVELAM HYDROCHLORIDE 625 MG per TAB